Amyloidosis other imaging findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Amyloidosis}}
{{Secondary amyloidosis}}
{{CMG}} {{shyam}}
{{CMG}} {{shyam}}



Revision as of 18:47, 1 November 2019

Secondary amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Secondary amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Amyloidosis other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Amyloidosis other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Amyloidosis other imaging findings

CDC on Amyloidosis other imaging findings

Amyloidosis other imaging findings in the news

Blogs on Amyloidosis other imaging findings

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Amyloidosis other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Overview

Tissue doppler echocardiography and myocardial strain rate imaging has been shown to be very sensitive for the assessment of myocardial dysfunction in restrictive cardiomyopathy. The developmend of serum amyloid P component (SAP) scans has given physicians the ability to specifically locate amyloid deposits.

Other Imaging Findings

  • In addition, all amyloid deposits contain serum amyloid P component (SAP), a circulating protein of the pentraxin family. Radionuclide SAP scans have been developed which can anatomically localize amyloid deposits in patients.[1]
  • Tissue doppler and myocardial strain rate imaging has been proven to be very sensitive for the assessment of myocardial dysfunction in restrictive cardiomyopathy. Doppler studies may show abnormal wall motion early in the disease process.
  • Abdominal ultrasound may reveal a swollen liver or spleen.
  • Thyroid ultrasound can help diagnose thyroidal involvement by amyloidosis.

References

  1. Pepys MB, Gallimore JR, Lloyd J, Li Z, Graham D, Taylor GW; et al. (2012). "Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use". J Immunol Methods. 384 (1–2): 92–102. doi:10.1016/j.jim.2012.07.013. PMC 4068106. PMID 22867744.

Template:WH Template:WS